AndhraNews.net
Home » Business News » 2012 » October » October 4, 2012

CellaVision Announces Distribution Agreement with Siemens for Digital Microscopy Hematology Solutions


October 4, 2012 - London

CellaVision announces the signing of a supply, distributorship, sales and service agreement - effective January 1, 2013 - with Siemens Healthcare Diagnostics through which Siemens is able to offer its clinical laboratory customers* access to CellaVision's leading-edge digital microscopy hematology products. The solutions available to customers compliment existing hematology products in the Siemens portfolio and complete the company's hematology offerings for high-volume laboratories.

Hematology products covered in the agreement, such as the CellaVision® DM96 and DM1200, are used by clinical laboratories for automated medical microscopy analysis. This process, which standardizes manual differential results, helps increase efficiency for routine work. CellaVision technology automates digital cell morphology, where cells are automatically located on a stained peripheral blood or body fluid smear, pre-classified, stored and presented for confirmation by a technologist. Ultimately, this accelerates turnaround time and produces better, more standardized differential results. Plus, through CellaVision's flexible software applications, remote users have real-time access to patients' cell images.

CellaVision's product line is the ideal addition to Siemens' already robust hematology portfolio and in particular, the Siemens ADVIA® 2120i Hematology System with Autoslide-an analyzer delivering advanced testing methodologies that automates hematology workflow without the need for large track-based systems, expensive stains or reflexive testing.

"The agreement with Siemens is part of our long term expansion strategy and strengthens our market leadership. CellaVision is very pleased to offer Siemens' hematology customers the opportunity to become users of the digital way of doing cell differentials. The confidence in our products and the trust in our company, shown by Siemens, make us very proud. It further proves that CellaVision is now the gold standard in digital analysis of cell differentials in blood and other body fluids," said Yvonne Mårtensson, CellaVision CEO."

"Siemens remains firmly committed to growing our hematology offerings for our customers, including the formation of strategic relationships that broaden our portfolio's depth and ensure laboratories have access to the most advanced tools available today," said Stefan Wolf, CEO, Hemostasis, Hematology, and Specialty Business Unit, Siemens Healthcare Diagnostics. "Through our collaboration with CellaVision, we can now deliver digital microscopy products to laboratories worldwide, expanding our practical automation solutions to help high-volume operations improve their workflow efficiency."

* Countries excluded: Canada, Japan, China, Sweden, Denmark, Finland, Norway and Iceland

This information is disclosed by CellaVision AB (publ) pursuant to the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was released for public disclosure on October 4, 2012 at 8.20 am CET.

For further information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 708 33 77 82. Email: yvonne.martensson@cellavision.com

Gian Sachdev, Senior Manager, Public & Media Relations, Siemens Healthcare
Phone: +1 508 660-4721. Email: gian.sachdev@siemens.com

About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The analyses often constitute important reference data for fast and correct diagnosis of illnesses, for example of infections and serious cancers. CellaVision's products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In 2011 sales were SEK 155 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund and the company has subsidiaries in the USA, Canada and Japan. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at www.cellavision.com.

About Siemens Healthcare Sector

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros. For further information please visit: www.siemens.com/healthcare.

Press Release as PDF



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: CellaVision AB via Thomson Reuters ONE

HUG#1646211

GlobeNewswire

Comment on this story

Share